You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 8, 2025

Drug Price Trends for CLINDAMYCIN-BENZOYL PEROX


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CLINDAMYCIN-BENZOYL PEROX

Average Pharmacy Cost for CLINDAMYCIN-BENZOYL PEROX

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CLINDAMYCIN-BENZOYL PEROX 1-5% 16714-0984-25 0.77610 GM 2025-01-22
CLINDAMYCIN-BENZOYL PEROX 1-5% 00378-8688-54 0.50822 GM 2025-01-22
CLINDAMYCIN-BENZOYL PEROX 1-5% 68462-0486-27 0.50822 GM 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Clindamycin Phosphate and Benzoyl Peroxide

Market Size and Growth Projections

The global market for Clindamycin Phosphate and Benzoyl Peroxide is experiencing significant growth, driven by increasing demand for effective acne treatments. As of 2023, the market size was estimated to be around USD 214 million[1][3].

  • Forecasted Market Size: By 2030, the market is projected to reach USD 322.8 million, with a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period of 2024-2030[1].
  • Alternative Forecast: Another projection suggests the market will reach USD 365.8 million by 2032, with a CAGR of 6.4% from 2024 to 2032[3].

Key Players

The market is dominated by several prominent pharmaceutical companies, each with significant market share and revenue.

  • Bausch Health: Headquartered in Laval, Canada, with a revenue of $8.0 billion in 2023[3].
  • Perrigo: Based in Allegan, Michigan, USA, with a revenue of $4.5 billion in 2023[3].
  • Mylan: Headquartered in Canonsburg, Pennsylvania, USA, with a revenue of $11.3 billion in 2023[3].
  • Tolmar: Located in Fort Collins, Colorado, USA, with a revenue of $600 million in 2023[3].
  • TARO: Headquartered in Haifa, Israel, with a revenue of $1.5 billion in 2023[3].
  • GSK (GlaxoSmithKline): Based in Brentford, England, with a revenue of $43.1 billion in 2023[3].

Applications and Types

Clindamycin Phosphate and Benzoyl Peroxide are primarily used for treating acne, but they are available in various formulations and concentrations.

  • Applications: Commonly used in hospitals and drug stores[1].
  • Types: Available in different concentrations such as 1.2%/2.5%, 1.2%/3.75%, 1%/5%, and 1%/3%[1].

Price Analysis

The prices of Clindamycin Phosphate and Benzoyl Peroxide products vary based on the concentration, quantity, and brand.

  • Generic and Brand Prices:
    • For a 35-gram supply of 5%-1% topical gel, the cost can range from $42.26 to $83.65[2].
    • For a 50-gram supply of 2.5%-1.2% topical gel, the cost can range from $137.00 to $189.91[2].
    • For a 50-gram supply of 3.75%-1.2% topical gel, the cost can be as high as $599.66 to $673.36[2].
    • The brand name Duac (5%-1%) topical gel can cost around $255 for a 45-gram supply[4].

Market Trends

Several trends are shaping the Clindamycin Phosphate and Benzoyl Peroxide market:

  • Launch of New Formulations: Companies are introducing innovative formulations with enhanced delivery systems to improve treatment efficacy[3].
  • Increased Online Presence: Major players are expanding their online retail strategies to make products more accessible through e-commerce platforms[3].
  • Telemedicine Integration: Dermatology clinics are adopting telemedicine, making it easier for patients to consult healthcare professionals remotely[3].
  • Sustainability Initiatives: Companies are focusing on eco-friendly packaging and sustainable production practices to appeal to environmentally conscious consumers[3].
  • Clinical Trials for Expanded Indications: Ongoing clinical trials are exploring the use of Clindamycin Phosphate and Benzoyl Peroxide for other skin conditions like rosacea, expanding their market potential[3].

Challenges and Opportunities

The market faces several challenges and opportunities:

  • Competition: The market is highly competitive, with multiple players vying for market share[3].
  • Regulatory Hurdles: Companies must navigate regulatory requirements, which can be a significant challenge[3].
  • Economic Factors: Economic fluctuations can impact the demand and pricing of these products[3].
  • Technological Advancements: Innovations in delivery systems and formulations offer opportunities for growth and market differentiation[3].

Regional Analysis

The market is segmented into several key regions:

  • North America: A significant market due to high demand for acne treatments[5].
  • Europe: Another major market with a strong presence of key players[5].
  • Asia Pacific: Growing rapidly due to increasing awareness and demand for skincare products[5].
  • Middle East & Africa: Emerging markets with potential for future growth[5].
  • Latin America: Also showing growth potential driven by increasing healthcare spending[5].

Consumer Behavior and Patient Assistance

Consumer behavior and patient assistance programs play a crucial role in the market:

  • Consumer Behavior: Consumers are increasingly seeking effective and convenient skincare solutions, driving the demand for Clindamycin Phosphate and Benzoyl Peroxide products[5].
  • Patient Assistance Programs: While there are no specific patient assistance programs for this medication, healthcare providers may have information on available programs in their area[2][4].

Key Takeaways

  • The Clindamycin Phosphate and Benzoyl Peroxide market is projected to grow significantly, reaching USD 322.8 million by 2030.
  • Key players include Bausch Health, Perrigo, Mylan, Tolmar, TARO, and GSK.
  • The market is driven by technological advancements, increasing demand, and regulatory support.
  • Challenges include competition, regulatory hurdles, and economic factors.
  • Trends such as new formulations, online presence, telemedicine integration, sustainability initiatives, and clinical trials for expanded indications are shaping the market.

FAQs

1. What is the forecasted market size for Clindamycin Phosphate and Benzoyl Peroxide by 2030?

The forecasted market size for Clindamycin Phosphate and Benzoyl Peroxide by 2030 is USD 322.8 million[1].

2. Who are the main players in the Clindamycin Phosphate and Benzoyl Peroxide market?

The main players include Bausch Health, Perrigo, Mylan, Tolmar, TARO, and GSK[1][3].

3. What are the common applications of Clindamycin Phosphate and Benzoyl Peroxide?

These products are commonly used in hospitals and drug stores for treating acne[1].

4. How much does a typical supply of Clindamycin Phosphate and Benzoyl Peroxide cost?

The cost can range from $42.26 for a 35-gram supply of 5%-1% topical gel to $599.66 for a 50-gram supply of 3.75%-1.2% topical gel, depending on the concentration and brand[2][4].

5. Are there any patient assistance programs available for Clindamycin Phosphate and Benzoyl Peroxide?

No specific patient assistance programs were found for this medication, but healthcare providers may have information on available programs in their area[2][4].

Cited Sources

  1. Valuates Reports: Global Clindamycin Phosphate and Benzoyl Peroxide Market[1].
  2. Drugs.com: Benzoyl peroxide/clindamycin topical Prices, Coupons, Copay Cards & Patient Assistance[2].
  3. OpenPR: Clindamycin Phosphate and Benzoyl Peroxide Market Size (USD 365.8 M) by 2032[3].
  4. Drugs.com: Duac Prices, Coupons, Copay Cards & Patient Assistance[4].
  5. Cognitive Market Research: Global Clindamycin Phosphate And Benzoyl Peroxide Market Report[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.